Anna Marzá Florensa

121 Hypertension awareness, treatment, and control in hypertensive CHD patients 5 Hypertension awareness Hypertension treatment Hypertension control Male Female Male Female Male Female Aware - - 11.95 (8.61-16.59) 13.32 (6.18-28.71) 1.58 (1.34-1.87) 1.21 (0.91-1.63) Age 65 years or older 1.03 (0.87-1.23) 1.31 (0.93-1.83) 1.09 (0.85-1.41) 1.02 (0.56-1.84) 0.80 (0.69-0.94) 0.93 (0.72-1.21) CAGB 1.31 (0.93-1.86) 1.38 (0.62-3.08) 0.57 (0.35-0.92) 0.97 (0.28-3.44) 0.88 (0.64-1.21) 1.19 (0.64-2.22) PTCA 1.36 (1.04-1.78) 1.45 (0.91-2.31) 0.95 (0.64-1.41) 2.37 (1.06-5.34) 0.89 (0.70-1.12) 0.98 (0.68-1.40) STEMI 1.03 (0.80-1.32) 0.80 (0.50-1.29) 0.79 (0.54-1.16) 2.60 (1.10-6.11) 0.98 (0.78-1.23) 1.11 (0.77-1.62) NSTEMI 1.01 (0.77-1.32) 1.12 (0.69-1.80) 0.92 (0.61-1.39) 1.41 (0.66-3.03) 0.82 (0.65-1.05) 0.90 (0.61-1.31) Secondary education 1.25 (0.94-1.67) 1.57 (1.00-2.48) 1.26 (0.86-1.85) 1.52 (0.73-3.18) 1.09 (0.84-1.41) 1.14 (0.78-1.66) Tertiary education 1.54 (1.15-2.06) 2.22 (1.36-3.62) 1.03 (0.70-1.51) 1.45 (0.65-3.25) 1.15 (0.89-1.50) 1.32 (0.88-1.96) Number of antihypertensive medications 1.24 (1.16-1.32) 1.25 (1.10-1.42) - - 1.15 (1.08-1.21) 1.03 (0.93-1.14) Adherent to medication 2.12 (1.65-2.72) 2.76 (1.69-4.51) - - 2.14 (1.69-2.72) 1.54 (1.02-2.32) Overweight or obese 1.19 (0.95-1.49) 1.11 (0.73-1.69) 1.05 (0.76-1.44) 1.41 (0.71-2.80) 0.72 (0.59-0.89) 0.76 (0.54-1.07) Diabetic 0.85 (0.72-1.01) 0.85 (0.61-1.18) 0.99 (0.77-1.27) 1.17 (0.66-2.10) 0.66 (0.57-0.77) 0.63 (0.48-0.82) LDL ≥1.8mmol/L 1.04 (0.87-1.24) 0.83 (0.57-1.19) 0.75 (0.58-0.98) 0.69 (0.34-1.41) 0.76 (0.65-0.89) 0.73 (0.54-0.99) Supplementary Table 1. Results multivariable analysis showing associations of co-variates with being aware, treated and controlled by sex.

RkJQdWJsaXNoZXIy MTk4NDMw